RU2013114313A - Противокариесные композиции и пробиотики/пребиотики - Google Patents
Противокариесные композиции и пробиотики/пребиотики Download PDFInfo
- Publication number
- RU2013114313A RU2013114313A RU2013114313/10A RU2013114313A RU2013114313A RU 2013114313 A RU2013114313 A RU 2013114313A RU 2013114313/10 A RU2013114313/10 A RU 2013114313/10A RU 2013114313 A RU2013114313 A RU 2013114313A RU 2013114313 A RU2013114313 A RU 2013114313A
- Authority
- RU
- Russia
- Prior art keywords
- cest
- seq
- antimicrobial
- cultivable
- bacterial strain
- Prior art date
Links
- 239000006041 probiotic Substances 0.000 title claims abstract 5
- 235000018291 probiotics Nutrition 0.000 title claims abstract 5
- 239000000203 mixture Substances 0.000 title claims 6
- 235000013406 prebiotics Nutrition 0.000 title claims 4
- 230000000675 anti-caries Effects 0.000 title 1
- 239000004599 antimicrobial Substances 0.000 claims abstract 16
- 230000000845 anti-microbial effect Effects 0.000 claims abstract 14
- 230000001580 bacterial effect Effects 0.000 claims abstract 10
- 210000000214 mouth Anatomy 0.000 claims abstract 9
- 208000035473 Communicable disease Diseases 0.000 claims abstract 6
- 235000013376 functional food Nutrition 0.000 claims abstract 5
- 239000003814 drug Substances 0.000 claims abstract 4
- 230000000529 probiotic effect Effects 0.000 claims abstract 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12J—VINEGAR; PREPARATION OR PURIFICATION THEREOF
- C12J1/00—Vinegar; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P39/00—Processes involving microorganisms of different genera in the same process, simultaneously
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1729—Cationic antimicrobial peptides, e.g. defensins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Marine Sciences & Fisheries (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Communicable Diseases (AREA)
Abstract
1. Поддающийся культивированию противомикробный бактериальный штамм, который выбирают из любого из следующих штаммов: СЕСТ 7746, СЕСТ 7747, СЕСТ 7773 и СЕСТ 7775.2. Поддающийся культивированию противомикробный бактериальный штамм, который выбирают из любого из следующих штаммов: СЕСТ 7746, СЕСТ 7747, СЕСТ 7773 и СЕСТ 7775 или их комбинации, для применения в качестве лекарственного средства.3. Поддающийся культивированию противомикробный бактериальный штамм, который выбирают из любого из следующих штаммов: СЕСТ 7746, СЕСТ 7747, СЕСТ 7773 и СЕСТ 7775 или их комбинации, для применения в качестве противомикробного средства.4. Поддающийся культивированию противомикробный бактериальный штамм, который выбирают из любого из следующих штаммов: СЕСТ 7746, СЕСТ 7747, СЕСТ 7773 и СЕСТ 7775 или их комбинации, для применения при лечении инфекционных заболеваний ротовой полости.5. Поддающийся культивированию противомикробный бактериальный штамм, который выбирают из любого из следующих штаммов: СЕСТ 7746, СЕСТ 7747, СЕСТ 7773 и СЕСТ 7775 или их комбинации, для применения в качестве пробиотика или функционального пищевого продукта, разработанного для улучшения состояния здоровья ротовой полости.6. Противомикробное соединение, которое включает последовательности SEQ ID NO: 8 или SEQ ID NO: 9, или Противомикробное соединение, кодируемое последовательностью ДНК, включающей любую из следующих последовательностей: SEQ ID NO: I, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5.7. Противомикробное соединение по п.6, или их комбинации, для применения в качестве лекарственного средства.8. Противомикробное соединение по п.6, или их комбинации, для применения в качестве противоми�
Claims (16)
1. Поддающийся культивированию противомикробный бактериальный штамм, который выбирают из любого из следующих штаммов: СЕСТ 7746, СЕСТ 7747, СЕСТ 7773 и СЕСТ 7775.
2. Поддающийся культивированию противомикробный бактериальный штамм, который выбирают из любого из следующих штаммов: СЕСТ 7746, СЕСТ 7747, СЕСТ 7773 и СЕСТ 7775 или их комбинации, для применения в качестве лекарственного средства.
3. Поддающийся культивированию противомикробный бактериальный штамм, который выбирают из любого из следующих штаммов: СЕСТ 7746, СЕСТ 7747, СЕСТ 7773 и СЕСТ 7775 или их комбинации, для применения в качестве противомикробного средства.
4. Поддающийся культивированию противомикробный бактериальный штамм, который выбирают из любого из следующих штаммов: СЕСТ 7746, СЕСТ 7747, СЕСТ 7773 и СЕСТ 7775 или их комбинации, для применения при лечении инфекционных заболеваний ротовой полости.
5. Поддающийся культивированию противомикробный бактериальный штамм, который выбирают из любого из следующих штаммов: СЕСТ 7746, СЕСТ 7747, СЕСТ 7773 и СЕСТ 7775 или их комбинации, для применения в качестве пробиотика или функционального пищевого продукта, разработанного для улучшения состояния здоровья ротовой полости.
6. Противомикробное соединение, которое включает последовательности SEQ ID NO: 8 или SEQ ID NO: 9, или Противомикробное соединение, кодируемое последовательностью ДНК, включающей любую из следующих последовательностей: SEQ ID NO: I, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5.
7. Противомикробное соединение по п.6, или их комбинации, для применения в качестве лекарственного средства.
8. Противомикробное соединение по п.6, или их комбинации, для применения в качестве противомикробной композиции.
9. Противомикробное соединение по п.6, или их комбинации, для применения в качестве пребиотика или функционального пищевого продукта, разработанного для улучшения состояния здоровья ротовой полости.
10. Противомикробное соединение по п.6, или их комбинации, для применения при лечении инфекционных заболеваний ротовой полости.
11. Пробиотическая/пребиотическая композиция или функциональный пищевой продукт, который включает, по меньшей мере, один противомикробный штамм по любому из пп.1-5, и/или, по меньшей мере, одно противомикробное соединение по любому из пп.6-10.
12. Медико-фармацевтическая композиция, которая включает, по меньшей мере, один противомикробный штамм по любому из пп.1-5, и/или, по меньшей мере, одно противомикробное соединение из пп.6-10.
13. Композиция для поддержания ротовой полости в здоровом состоянии, которая включает, по меньшей мере, один противомикробный штамм по любому из пп.1-5 и/или, по меньшей мере, одно Противомикробное соединение из пп.6-10.
14. Пробиотическая/пребиотическая композиция или функциональный пищевой продукт по п.11 для применения при лечении инфекционных заболеваний ротовой полости.
15. Медико-фармацевтическая композиция по п.12 для применения при лечении инфекционных заболеваний ротовой полости.
16. Композиция для поддержания ротовой полости в здоровом состоянии по п.13 для применения при лечении инфекционных заболеваний ротовой полости.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ESP201031302 | 2010-08-31 | ||
ES201031302 | 2010-08-31 | ||
PCT/ES2011/070609 WO2012028759A2 (es) | 2010-08-31 | 2011-08-31 | Composiciones y probióticos/prebióticos anticaries |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2013114313A true RU2013114313A (ru) | 2014-10-10 |
RU2650866C2 RU2650866C2 (ru) | 2018-04-17 |
Family
ID=44936297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2013114313A RU2650866C2 (ru) | 2010-08-31 | 2011-08-31 | Противокариесные композиции и пробиотики/пребиотики |
Country Status (14)
Country | Link |
---|---|
US (1) | US9629883B2 (ru) |
EP (1) | EP2612904B1 (ru) |
JP (1) | JP5921546B2 (ru) |
KR (1) | KR101739802B1 (ru) |
CN (1) | CN103119153B (ru) |
AU (1) | AU2011298235B2 (ru) |
BR (1) | BR112013004702A2 (ru) |
CA (1) | CA2808793C (ru) |
ES (1) | ES2608577T3 (ru) |
IL (1) | IL224767A (ru) |
MX (1) | MX343566B (ru) |
PL (1) | PL2612904T3 (ru) |
RU (1) | RU2650866C2 (ru) |
WO (1) | WO2012028759A2 (ru) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10206959B2 (en) | 2013-02-14 | 2019-02-19 | University Of Florida Research Foundation, Inc. | Probiotic arginolytic oral compositions and methods of making and using probiotic arginolytic oral compositions |
WO2014127066A1 (en) * | 2013-02-14 | 2014-08-21 | University Of Florida Research Foundation, Inc. | Probiotic arginolytic oral compositions and methods of making and using probiotic arginolytic oral compositions |
WO2017044902A1 (en) * | 2015-09-09 | 2017-03-16 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for oral health |
CN105193859A (zh) * | 2015-09-25 | 2015-12-30 | 南昌大学 | 一种天然口腔细菌移植在口腔疾病治疗中的应用 |
CN105193857A (zh) * | 2015-09-25 | 2015-12-30 | 南昌大学 | 一种人工培养口腔细菌移植在口腔疾病治疗中的应用 |
EP3196318A1 (en) | 2016-01-19 | 2017-07-26 | Symrise AG | Probiotics for altering the composition of oral biofilms |
WO2018096118A1 (en) * | 2016-11-24 | 2018-05-31 | Servizo Galego De Saúde (Sergas) | Antimicrobial strain |
EP3351259A1 (en) | 2017-01-18 | 2018-07-25 | Symrise AG | Probiotics for aggregation with disease-associated species in the oral cavity |
US10733214B2 (en) | 2017-03-20 | 2020-08-04 | International Business Machines Corporation | Analyzing metagenomics data |
CN107460150B (zh) * | 2017-09-18 | 2020-03-24 | 沈阳医学院 | Dentisani链球菌及其应用和应用其的产品 |
CN107557317B (zh) * | 2017-09-20 | 2020-03-24 | 沈阳医学院 | 缓症链球菌及其应用和应用其的产品 |
IL293620A (en) * | 2019-12-06 | 2022-08-01 | Forsyth Dental Infirmary For Children | Methods and preparations for the prevention and treatment of tooth decay |
CN112011627B (zh) * | 2020-09-27 | 2022-02-25 | 赤峰家育种猪生态科技集团有限公司 | 与加系大白猪背膘厚相关的分子标记及筛选方法和应用 |
CN114317783B (zh) * | 2021-12-08 | 2023-07-28 | 上海锐翌医学检验实验室有限公司 | 龋齿标志微生物及其应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1321962C (en) | 1985-03-20 | 1993-09-07 | Aizo Matsushiro | Dental caries preventive preparations and method for preparing said preparations |
US5607672A (en) * | 1995-06-07 | 1997-03-04 | University Of Florida Research Foundation, Inc. | Replacement therapy for dental caries |
KR100266752B1 (ko) * | 1997-08-07 | 2001-03-02 | 오종석 | 인체 구강내 치태형성을 억제하는 신규한 유산균 |
US20030077814A1 (en) * | 1997-08-07 | 2003-04-24 | Oh Jong Suk | Novel lactic acid bacteria |
JP2002000261A (ja) | 2000-06-28 | 2002-01-08 | Ozeki Corp | 防菌剤 |
EP1483366B1 (en) * | 2002-02-22 | 2010-04-14 | Blis Technologies Limited | Antimicrobial composition |
JP4181806B2 (ja) | 2002-07-10 | 2008-11-19 | シャープ株式会社 | 印刷版、印刷機および印刷方法ならびに液晶機器の製造装置および製造方法 |
US20060258596A1 (en) | 2003-02-14 | 2006-11-16 | Walsh Timothy R | Antimicrobial agents |
CN102389390A (zh) | 2003-08-11 | 2012-03-28 | 奥洁克公司 | 维持口腔健康的组合物及方法 |
EP1634948A1 (en) * | 2004-09-10 | 2006-03-15 | Basf Aktiengesellschaft | Means and methods for preventing and/or treating caries |
WO2007077210A1 (en) | 2006-01-04 | 2007-07-12 | Wikstroem Maude | Probiotic oral health promoting product |
-
2011
- 2011-08-31 WO PCT/ES2011/070609 patent/WO2012028759A2/es active Application Filing
- 2011-08-31 PL PL11781828T patent/PL2612904T3/pl unknown
- 2011-08-31 ES ES11781828.6T patent/ES2608577T3/es active Active
- 2011-08-31 EP EP11781828.6A patent/EP2612904B1/en active Active
- 2011-08-31 CN CN201180041987.6A patent/CN103119153B/zh active Active
- 2011-08-31 US US13/819,261 patent/US9629883B2/en active Active
- 2011-08-31 KR KR1020137006071A patent/KR101739802B1/ko active IP Right Grant
- 2011-08-31 JP JP2013526517A patent/JP5921546B2/ja active Active
- 2011-08-31 RU RU2013114313A patent/RU2650866C2/ru active
- 2011-08-31 MX MX2013002247A patent/MX343566B/es active IP Right Grant
- 2011-08-31 CA CA2808793A patent/CA2808793C/en active Active
- 2011-08-31 AU AU2011298235A patent/AU2011298235B2/en active Active
- 2011-08-31 BR BR112013004702-0A patent/BR112013004702A2/pt not_active Application Discontinuation
-
2013
- 2013-02-17 IL IL224767A patent/IL224767A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CA2808793C (en) | 2020-09-22 |
JP2013543374A (ja) | 2013-12-05 |
EP2612904A2 (en) | 2013-07-10 |
ES2608577T3 (es) | 2017-04-12 |
MX343566B (es) | 2016-11-09 |
KR101739802B1 (ko) | 2017-05-25 |
MX2013002247A (es) | 2013-07-03 |
BR112013004702A2 (pt) | 2018-09-04 |
PL2612904T3 (pl) | 2017-07-31 |
KR20140001832A (ko) | 2014-01-07 |
EP2612904B1 (en) | 2016-09-21 |
IL224767A (en) | 2017-02-28 |
CN103119153A (zh) | 2013-05-22 |
AU2011298235A1 (en) | 2013-04-18 |
US20140147426A1 (en) | 2014-05-29 |
CA2808793A1 (en) | 2012-03-08 |
CN103119153B (zh) | 2016-03-23 |
JP5921546B2 (ja) | 2016-05-24 |
AU2011298235B2 (en) | 2016-07-21 |
RU2650866C2 (ru) | 2018-04-17 |
WO2012028759A3 (es) | 2012-08-02 |
WO2012028759A2 (es) | 2012-03-08 |
US9629883B2 (en) | 2017-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2013114313A (ru) | Противокариесные композиции и пробиотики/пребиотики | |
BR112013003761A2 (pt) | composição probiótica para saúde oral | |
MX348653B (es) | Derivados ester de acido boronico ciclico y sus usos terapeuticos. | |
MX354047B (es) | Cepas/celulas de lactobacillus secadas por aspersion, y el uso de las mismas contra helicobacter pylori. | |
BR112013016493A2 (pt) | uso de um microrganismo com capacidade de ligação ou fragmento deste, método de preparar uma composição, composição, e, microrganismo com capacidade de ligação ou fragmento deste | |
PH12019500714A1 (en) | Antiseptic-tolerant lactic acid bacteria | |
MX2013004817A (es) | Enfermedad inflamatoria. | |
WO2011110655A3 (en) | Immunogenic composition or vaccine against gram - negative bacterial, for example neiserial, infection or disease | |
WO2014018596A3 (en) | Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides | |
WO2012112777A3 (en) | Biosynthesis of human milk oligosaccharides in engineered bacteria | |
MX2011009539A (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso. | |
MX2018000488A (es) | Composicion de autoformacion de pelicula para el cuidado oral. | |
BR112013028709A2 (pt) | cepas bacterianas capazes de metabolizar oxalatos | |
BRPI1011277B8 (pt) | produto de bacteriocina lactobacillus pentosus, alimento e composições farmacêuticas contendo o mesmo e uso do mesmo | |
RU2010147343A (ru) | ИЗОЛИРОВАННЫЙ ШТАММ МИКРООРГАНИЗМА Lactobacillus plantarum Inducia DSM 21379 В КАЧЕСТВЕ ПРОБИОТИКА, УСИЛИВАЮЩЕГО ВРОЖДЕННЫЙ ИММУНИТЕТ ОРГАНИЗМА, ПРОДУКТ И КОМПОЗИЦИЯ, СОДЕРЖАЩИЕ УПОМОМЯНУТЫЙ МИКРООРГАНИЗМ, И ПРИМЕНЕНИЕ УПОМЯНУТОГО МИКРООРГАНИЗМА ДЛЯ ИЗГОТОВЛЕНИЯ ЛЕКАРСТВЕННОГО СРЕДСТВА, КОТОРОЕ УСИЛИВАЕТ КЛЕТОЧНЫЙ ИММУНИТЕТ | |
EA201390305A1 (ru) | Композиции для влагалищного и перорального введения lactobacillus и их применение | |
RU2011139211A (ru) | Бактериальные штаммы, обладающие высокой противовоспалительной активностью | |
EP2371347A3 (en) | Oral care compositions | |
IN2012DN01638A (ru) | ||
AU2011350554A8 (en) | Interferon production-inducing agent containing lactic acid bacteria | |
MX2013004372A (es) | Productos de confiteria que contienen microorganismos probioticos. | |
UA107711C2 (en) | Use of lactobacilli inhibiting gas producing coliform bacteria isolated from infants affected by colic | |
NZ744342A (en) | Probiotics for use as anti-inflammatory agents in the oral cavity | |
UA100551C2 (en) | Synbiotic mixture | |
NZ706636A (en) | Probiotic and prebiotic compositions |